Novo Holdings A/S Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$1.1T
Holdings
22
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (22 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | INGNINOGEN INC | 3,549,320 | $238.4B | 22.70% | |
| 2 | VTIVANGUARD INDEX FDS | 1,623,100 | $187.2B | 17.83% | |
| 3 | —COLUCID PHARMACEUTICALS INC | 3,156,563 | $114.9B | 10.94% | |
| 4 | VGKVANGUARD INTL EQUITY INDEX F | 2,101,000 | $100.7B | 9.59% | |
| 5 | RETAEURREATA PHARMACEUTICALS INC | 3,367,763 | $73.5B | 7.00% | |
| 6 | IRTCIRHYTHM TECHNOLOGIES INC | 2,024,448 | $60.7B | 5.78% | |
| 7 | CRVSCORVUS PHARMACEUTICALS INC | 3,224,046 | $46.1B | 4.39% | |
| 8 | XLRNACCELERON PHARMA INC | 1,240,173 | $31.6B | 3.01% | |
| 9 | —RA PHARMACEUTICALS INC | 2,031,562 | $30.9B | 2.94% | |
| 10 | MRUSMERUS N V | 1,410,417 | $29.8B | 2.84% | |
| 11 | —SPECTRANETICS CORP | 1,179,122 | $28.9B | 2.75% | |
| 12 | —FLEXION THERAPEUTICS INC | 1,397,718 | $26.6B | 2.53% | |
| 13 | KALVKALVISTA PHARMACEUTICALS INC | 2,901,927 | $20.5B | 1.95% | |
| 14 | —APOLLO ENDOSURGERY INC | 1,456,972 | $17.7B | 1.69% | |
| 15 | —NABRIVA THERAPEUTICS AG | 2,326,544 | $13.9B | 1.32% | |
| 16 | —INVUITY INC | 1,318,448 | $7.6B | 0.72% | |
| 17 | —DERMIRA INC | 216,562 | $6.6B | 0.63% | |
| 18 | —WRIGHT MED GROUP N V | 4,622,032 | $6.1B | 0.58% | |
| 19 | CRSPCRISPR THERAPEUTICS AG | 223,317 | $4.5B | 0.43% | |
| 20 | —HTG MOLECULAR DIAGNOSTICS INC | 1,280,185 | $2.9B | 0.27% | |
| 21 | XENEXENON PHARMACEUTICALS INC | 127,563 | $982.0M | 0.09% | |
| 22 | OPKOPKO HEALTH INC | 259 | $2.0M | 0.00% |